XIL_health_forLight.png
XIL Health CEO and Founder, Susan Lang, Makes Inc.’s 2022 Female Founders 100 List
October 03, 2022 09:08 ET | XIL Health
ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic technology and analytics company in the drug economic space, today announces that its CEO and founder, Susan Lang, has...
XIL_health_forLight.png
XIL Health Ranks No. 945 on the 2022 Inc. 5000 List, Experiencing Rapid Growth with XIL Impact Expansion
August 16, 2022 10:14 ET | XIL Health
ST. LOUIS, Aug. 16, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug space, today announces its ranking on Inc. Magazine’s annual Inc. 5000 list...
XIL_health_forLight.png
XIL Health Develops Interactive Vaccine Dashboard with COVID Tracker for Pharmacies Nationwide
February 15, 2022 09:00 ET | XIL Health
ST. LOUIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug economics space that built the XIL Impact SaaS platform, today announces its...
XIL_health_forLight.png
XIL Health’s VP of Client Growth & Innovation Recognized as an OBJ 2021 Power Player for Industry Disruption
September 22, 2021 09:00 ET | XIL Health
LAKE NONA, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Alexandra Robertson, XIL Health’s Vice President of Client Growth & Innovation, has been named an Orlando Business Journal 2021 Power Player...
XIL_health_forLight.png
XIL Health Announces XIL Impact, Offering Pharmacy Executives Complete Look at Finances, Analytics, Insights to Negotiate Drug Reimbursements in Contentious Marketplace
June 01, 2021 09:00 ET | XIL Health
ST. LOUIS, June 01, 2021 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug economics space, announces its latest technology suite, XIL Impact – a...